JP2007517775A5 - - Google Patents

Download PDF

Info

Publication number
JP2007517775A5
JP2007517775A5 JP2006544089A JP2006544089A JP2007517775A5 JP 2007517775 A5 JP2007517775 A5 JP 2007517775A5 JP 2006544089 A JP2006544089 A JP 2006544089A JP 2006544089 A JP2006544089 A JP 2006544089A JP 2007517775 A5 JP2007517775 A5 JP 2007517775A5
Authority
JP
Japan
Prior art keywords
composition
vegi
polypeptide
cancer
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006544089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007517775A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/041729 external-priority patent/WO2005058243A2/en
Publication of JP2007517775A publication Critical patent/JP2007517775A/ja
Publication of JP2007517775A5 publication Critical patent/JP2007517775A5/ja
Pending legal-status Critical Current

Links

JP2006544089A 2003-12-11 2004-12-13 血管内皮細胞増殖インヒビターであるｖｅｇｉ−１９２ａを使用して、癌を処置するための方法 Pending JP2007517775A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52917303P 2003-12-11 2003-12-11
US53665304P 2004-01-13 2004-01-13
PCT/US2004/041729 WO2005058243A2 (en) 2003-12-11 2004-12-13 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a

Publications (2)

Publication Number Publication Date
JP2007517775A JP2007517775A (ja) 2007-07-05
JP2007517775A5 true JP2007517775A5 (https=) 2007-11-22

Family

ID=34704267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006544089A Pending JP2007517775A (ja) 2003-12-11 2004-12-13 血管内皮細胞増殖インヒビターであるｖｅｇｉ−１９２ａを使用して、癌を処置するための方法

Country Status (4)

Country Link
US (1) US20050233961A1 (https=)
EP (1) EP1691764A2 (https=)
JP (1) JP2007517775A (https=)
WO (1) WO2005058243A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583268B2 (en) * 2000-01-25 2003-06-24 Oklahoma Medical Research Foundation Universal procedure for refolding recombinant proteins
CA2465953A1 (en) * 2001-11-09 2003-05-15 Georgetown University Novel isoforms of vascular endothelial cell growth inhibitor
WO2007062270A2 (en) * 2005-11-28 2007-05-31 Proteomtech Inc. Methods for production of recombinant alpha1-antitrypsin
WO2010138123A1 (en) * 2009-05-28 2010-12-02 Proteomtech, Inc. P53 fusion proteins and methods of making and using thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US7597886B2 (en) * 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US20020111325A1 (en) * 1997-11-03 2002-08-15 Human Genome Sciences, Inc. VEGI, an inhibitor of angiogenesis and tumor growth
US6583268B2 (en) * 2000-01-25 2003-06-24 Oklahoma Medical Research Foundation Universal procedure for refolding recombinant proteins
CA2465953A1 (en) * 2001-11-09 2003-05-15 Georgetown University Novel isoforms of vascular endothelial cell growth inhibitor
CN1311076C (zh) * 2003-04-16 2007-04-18 普罗特奥姆技术公司 生产重组尿激酶的方法

Similar Documents

Publication Publication Date Title
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
WO2006034373A8 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
JP2004534850A5 (https=)
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
HRP20041108B1 (hr) Peptidi povezani sa tumorom koji se vežu na mhc molekule
WO2002083171A3 (en) Cancer treatment by using fap-alpha specific antibodies
MX2008009493A (es) Peptido novedoso y uso del mismo.
RU2007145489A (ru) Фармацевтические композиции и способы лечения рака и его метастазов
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
JP2007517775A5 (https=)
WO2006048450A3 (en) Peptides for use in the treating obesity
SE0401631D0 (sv) New Composition
WO2006048452A3 (en) Peptides for use in treating of obesity
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
WO2007120555A3 (en) Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphism
JP2005523891A5 (https=)
WO2006103494A3 (en) Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
JP2008533976A5 (https=)
DE60222669D1 (de) Asthma-assoziiertes gen
WO2004022104A3 (en) Foxp2 and uses thereof
DE60331166D1 (de) Splice variante des menschlichen hypophysären wachstumshormons